Apoptosis
"Apoptosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
| Descriptor ID |
D017209
|
| MeSH Number(s) |
G04.146.160
|
| Concept/Terms |
Apoptosis- Apoptosis
- Programmed Cell Death, Type I
|
Below are MeSH descriptors whose meaning is more general than "Apoptosis".
Below are MeSH descriptors whose meaning is more specific than "Apoptosis".
This graph shows the total number of publications written about "Apoptosis" by people in this website by year, and whether "Apoptosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 9 | 5 | 14 | | 1997 | 13 | 5 | 18 | | 1998 | 11 | 7 | 18 | | 1999 | 15 | 12 | 27 | | 2000 | 19 | 15 | 34 | | 2001 | 23 | 17 | 40 | | 2002 | 45 | 27 | 72 | | 2003 | 30 | 29 | 59 | | 2004 | 36 | 32 | 68 | | 2005 | 36 | 33 | 69 | | 2006 | 42 | 34 | 76 | | 2007 | 31 | 31 | 62 | | 2008 | 31 | 50 | 81 | | 2009 | 34 | 44 | 78 | | 2010 | 30 | 54 | 84 | | 2011 | 35 | 49 | 84 | | 2012 | 35 | 64 | 99 | | 2013 | 30 | 55 | 85 | | 2014 | 23 | 60 | 83 | | 2015 | 18 | 53 | 71 | | 2016 | 20 | 46 | 66 | | 2017 | 15 | 39 | 54 | | 2018 | 12 | 34 | 46 | | 2019 | 11 | 48 | 59 | | 2020 | 8 | 37 | 45 | | 2021 | 5 | 23 | 28 | | 2022 | 1 | 17 | 18 | | 2023 | 0 | 17 | 17 | | 2024 | 4 | 17 | 21 | | 2025 | 7 | 23 | 30 | | 2026 | 3 | 7 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Apoptosis" by people in Profiles.
-
Valenti WB, Ruzzene ST, Berry AR, Orozco-Fersiva NC, Stone MF, Gilmore EC, Holzer JP, Mollaian JS, Greiner JJ, Garcia VP, DeSouza CA. Effect of 17ß-estradiol on brain microvascular endothelial cell oxidative stress, apoptotic susceptibility, and fibrinolytic capacity. J Appl Physiol (1985). 2026 Jun 01; 140(6):1804-1812.
-
Zöller M, Mastalerz M, Dick E, Merl-Pham J, Hennen E, Prakki SRS, Chakraborty A, Nakayama M, Klotz M, Marchi H, LeGleut R, De Sadeleer LJ, Wuyts WA, Vanaudenaerde BM, Jeridi A, Prasse A, Jäger B, Santofimia-Castaño P, Stoleriu MG, Hilgendorff A, Hauck SM, Yildirim AÖ, Schiller H, Staab-Weijnitz CA. Nuclear protein 1 is a cell death regulator in primary human airway epithelial cells and reduced in idiopathic pulmonary fibrosis. Sci Rep. 2026 May 11; 16(1).
-
Orr L, Golding H, O'Brien E, Siauw J, Su TT. Pink1 represses apoptosis and allows proper morphogenesis after exposure to ionizing radiation in Drosophila melanogaster. Genetics. 2026 May 06; 233(1).
-
Parween S, Saviola AJ, Howell AC, Varghese S, Galindo DC, Vergara MN. Human retinal organoid model of disease-relevant photoreceptor cell death amenable to drug screening. Cell Death Dis. 2026 Apr 13; 17(1).
-
Chakraborty N, Patel M, Kannan S, Moyler C, Dimitrov G, Gautam A, Newman M, Hendry-Hofer TB, Boyd J, Hammamieh R. Fentanyl-induced cortical and cardiopulmonary damage linked to immune response functions and apoptosis-necrosis networks in a multi-omics mouse model. Front Immunol. 2026; 17:1694651.
-
Redente EF, Song T, Javkhlan N, Edelman BL, Foster DG, Wilson JA, Chakraborty S, Cooley JC, Gaurav R, Saguthi S, Seibold MA, Blumhagen RZ, Schwartz DA, Yang IV, Matsuda J, Bridges JP, Zemans RL, Tuder RM, Riches DWH. Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 Inhibition. Nat Commun. 2026 Feb 28; 17(1).
-
Wang SZ, Timken JP, Hong ES, Kaur S, Newby E, Kay KE, Mulkearns-Hubert EE, Silver DJ, Lee J, Rubin JB, Connor JR, Deleyrolle LP, Tiek D, Dhawan A, Lathia JD. Lipocalin 2 orchestrates resistance to ferroptosis via AXL. Cell Rep. 2026 Mar 24; 45(3):116965.
-
Schiavon A, Evaristo C, Saba L, Petiti J, Pignochino Y, Puglisi S, Perotti P, Messina E, Giachino C, Terzolo M, Lo Iacono M. Targeting ER stress in adrenocortical carcinoma: Celastrol as a novel therapeutic candidate. Biomed Pharmacother. 2026 Apr; 197:119156.
-
Gu W, Ren Z, Gao J, Shen Z, Wang Y, Xu L, Qian R, Miao Q, Wu Y, Hu X, Wu Y, Liu W, Wan CC, Sun L, Cai Y, Sang M, Zheng C, Yan T. Inhibiting NAT10 suppresses hepatocellular carcinoma progression by reducing Nrf2 mRNA stability and increasing oxidative stress. Chem Biol Interact. 2026 Apr 25; 429:111972.
-
Zhou Y, Nakajima R, Shirasawa M, Fikriyanti M, Watanabe A, Yang C, Iwanaga R, Bradford AP, Kurayoshi K, Araki K, Ohtani K. Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells. Cells. 2026 Jan 05; 15(1).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|